FDA Inspection
Daniel L. Peterson, M.D.Daniel L. Peterson, M.D. – FDA Inspection, Jan 9, 2013
Record Details
This FDA Inspection record concerns Daniel L. Peterson, M.D., with an inspection on January 9, 2013, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Daniel L. Peterson, M.D.
- Inspection Date
- January 9, 2013
- Product Type
- Drugs
View Company Profile
ID · 37b2cde6-d679-40f2-93a0-19110ac6e278
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 813421
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Daniel L. Peterson, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 17, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Daniel L. Peterson, M.D.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.